These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27592098)

  • 1. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic.
    Stempel H; Dodge A; Marriott E; Peterson AL
    J Pediatr; 2016 Nov; 178():285-287. PubMed ID: 27592098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia in children: Why and how to screen for it?
    Girardet JP; Bocquet A; Chouraqui JP; Darmaun D; Feillet F; Frelut ML; Hankard R; Rozé JC; Simeoni U; Turck D; Briend A; Dupont C;
    Arch Pediatr; 2018 Apr; 25(3):175-176. PubMed ID: 29548557
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal Screening for Familial Hypercholesterolemia in Children.
    Klančar G; Grošelj U; Kovač J; Bratanič N; Bratina N; Trebušak Podkrajšek K; Battelino T
    J Am Coll Cardiol; 2015 Sep; 66(11):1250-1257. PubMed ID: 26361156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cascade Screening in Familial Hypercholesterolemia: Advancing Forward.
    Santos RD; Frauches TS; Chacra AP
    J Atheroscler Thromb; 2015; 22(9):869-80. PubMed ID: 26194978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse Cascade Screening for Familial Hypercholesterolemia.
    Vinson A; Guerra L; Hamilton L; Wilson DP; Fnla
    J Pediatr Nurs; 2019; 44():50-55. PubMed ID: 30683281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cascade screening of familial hypercholesterolemia must go on.
    Galema-Boers JM; Versmissen J; Roeters van Lennep HW; Dusault-Wijkstra JE; Williams M; Roeters van Lennep JE
    Atherosclerosis; 2015 Oct; 242(2):415-7. PubMed ID: 26282946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting familial hypercholesterolemia: The Jack and the Beanstalk principle.
    Martin AC; Allen C; Pang J; Watts GF
    J Clin Lipidol; 2017; 11(2):575-578. PubMed ID: 28502516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17).
    Miller PE; Martin SS; Toth PP; Santos RD; Blaha MJ; Nasir K; Virani SS; Post WS; Blumenthal RS; Jones SR
    J Clin Lipidol; 2015; 9(5):676-83. PubMed ID: 26350814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G; Ose L
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal lipid screening in adolescents to identify familial hypercholesterolemia in a large healthcare system.
    Cortez AB; Salvador M; Li Q; Briscoe A
    J Clin Lipidol; 2024; 18(2):e166-e175. PubMed ID: 38172009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia.
    Silva PRS; Jannes CE; Oliveira TGM; Gómez LMG; Krieger JE; Santos RD; Pereira AC
    Arq Bras Cardiol; 2018 Oct; 111(4):578-584. PubMed ID: 30156605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
    Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
    J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Screening in Children.
    Daniels SR
    J Am Coll Cardiol; 2015 Sep; 66(11):1258-1260. PubMed ID: 26361157
    [No Abstract]   [Full Text] [Related]  

  • 15. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
    Marks D; Thorogood M; Neil SM; Humphries SE; Neil HA
    J Med Screen; 2006; 13(3):156-9. PubMed ID: 17007658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of familial hypercholesterolemia in children and adolescents].
    Ose L; Tonstad S; Vesterhus P; Wefring KW
    Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3499-503. PubMed ID: 7491603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypercholesterolemia in children and young adults: should screening be done?].
    Keller U
    Schweiz Med Wochenschr; 1995 Feb; 125(7):255-63. PubMed ID: 7878403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods.
    Ibrahim S; Reeskamp LF; Stroes ESG; Watts GF
    Curr Opin Lipidol; 2020 Dec; 31(6):347-355. PubMed ID: 33027222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.